348 related articles for article (PubMed ID: 26609229)
21. Impact of mild exacerbation on COPD symptoms in a Japanese cohort.
Sato M; Chubachi S; Sasaki M; Haraguchi M; Kameyama N; Tsutsumi A; Takahashi S; Nakamura H; Asano K; Betsuyaku T
Int J Chron Obstruct Pulmon Dis; 2016; 11():1269-78. PubMed ID: 27354785
[TBL] [Abstract][Full Text] [Related]
22. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations.
Calverley PM; Postma DS; Anzueto AR; Make BJ; Eriksson G; Peterson S; Jenkins CR
Int J Chron Obstruct Pulmon Dis; 2016; 11():381-90. PubMed ID: 26952309
[TBL] [Abstract][Full Text] [Related]
23. Long-term prognosis of asthma, chronic obstructive pulmonary disease, and asthma-chronic obstructive pulmonary disease overlap in the Copenhagen City Heart study: a prospective population-based analysis.
Lange P; Çolak Y; Ingebrigtsen TS; Vestbo J; Marott JL
Lancet Respir Med; 2016 Jun; 4(6):454-62. PubMed ID: 27061878
[TBL] [Abstract][Full Text] [Related]
24. Development of the ProPal-COPD tool to identify patients with COPD for proactive palliative care.
Duenk RG; Verhagen C; Bronkhorst EM; Djamin RS; Bosman GJ; Lammers E; Dekhuijzen P; Vissers K; Engels Y; Heijdra Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():2121-2128. PubMed ID: 28790815
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for acute exacerbations of COPD in a primary care population: a retrospective observational cohort study.
Müllerová H; Shukla A; Hawkins A; Quint J
BMJ Open; 2014 Dec; 4(12):e006171. PubMed ID: 25524545
[TBL] [Abstract][Full Text] [Related]
26. Impact of exacerbations on respiratory system impedance measured by a forced oscillation technique in COPD: a prospective observational study.
Kamada T; Kaneko M; Tomioka H
Int J Chron Obstruct Pulmon Dis; 2017; 12():509-516. PubMed ID: 28223791
[TBL] [Abstract][Full Text] [Related]
27. The effect of comorbidities on COPD assessment: a pilot study.
Weinreich UM; Thomsen LP; Bielaska B; Jensen VH; Vuust M; Rees SE
Int J Chron Obstruct Pulmon Dis; 2015; 10():429-38. PubMed ID: 25750525
[TBL] [Abstract][Full Text] [Related]
28. Validation of the GOLD 2017 and new 16 subgroups (1A-4D) classifications in predicting exacerbation and mortality in COPD patients.
Han MZ; Hsiue TR; Tsai SH; Huang TH; Liao XM; Chen CZ
Int J Chron Obstruct Pulmon Dis; 2018; 13():3425-3433. PubMed ID: 30425472
[TBL] [Abstract][Full Text] [Related]
29. Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.
Calle Rubio M; Casamor R; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2017; 12():2373-2383. PubMed ID: 28848338
[TBL] [Abstract][Full Text] [Related]
30. Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD.
Fan VS; Ramsey SD; Make BJ; Martinez FJ
COPD; 2007 Mar; 4(1):29-39. PubMed ID: 17364675
[TBL] [Abstract][Full Text] [Related]
31. Prediction of first acute exacerbation using COPD subtypes identified by cluster analysis.
Yoon HY; Park SY; Lee CH; Byun MK; Na JO; Lee JS; Lee WY; Yoo KH; Jung KS; Lee JH
Int J Chron Obstruct Pulmon Dis; 2019; 14():1389-1397. PubMed ID: 31388298
[TBL] [Abstract][Full Text] [Related]
32. 'Exacerbation-free time' to assess the impact of exacerbations in patients with chronic obstructive pulmonary disease (COPD): a prospective observational study.
Boer LM; Bischoff EW; Borgijink X; Vercoulen JH; Akkermans RP; Kerstjens HAM; Assendelft WJ; Schermer TR
NPJ Prim Care Respir Med; 2018 Apr; 28(1):12. PubMed ID: 29615628
[TBL] [Abstract][Full Text] [Related]
33. Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.
Jeong SH; Lee H; Carriere KC; Shin SH; Moon SM; Jeong BH; Koh WJ; Park HY
Int J Chron Obstruct Pulmon Dis; 2016; 11():1857-65. PubMed ID: 27536097
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of a COPD population categorised using the GOLD framework by health status and exacerbations.
Jones PW; Nadeau G; Small M; Adamek L
Respir Med; 2014 Jan; 108(1):129-35. PubMed ID: 24041746
[TBL] [Abstract][Full Text] [Related]
35. Characterisation of the frequent exacerbator phenotype in COPD patients in a large UK primary care population.
McGarvey L; Lee AJ; Roberts J; Gruffydd-Jones K; McKnight E; Haughney J
Respir Med; 2015 Feb; 109(2):228-37. PubMed ID: 25613107
[TBL] [Abstract][Full Text] [Related]
36. Emphysematous phenotype is an independent predictor for frequent exacerbation of COPD.
Oh YM; Sheen SS; Park JH; Jin UR; Yoo JW; Seo JB; Yoo KH; Lee JH; Kim TH; Lim SY; Yoon HI; Lee JS; Lee SD
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1407-14. PubMed ID: 25517804
[TBL] [Abstract][Full Text] [Related]
37. The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS).
Miravitlles M; Worth H; Soler-Cataluña JJ; Price D; De Benedetto F; Roche N; Godtfredsen NS; van der Molen T; Löfdahl CG; Padullés L; Ribera A
COPD; 2016 Oct; 13(5):561-8. PubMed ID: 26983349
[TBL] [Abstract][Full Text] [Related]
38. No association between exacerbation frequency and stroke in patients with COPD.
Windsor C; Herrett E; Smeeth L; Quint JK
Int J Chron Obstruct Pulmon Dis; 2016; 11():217-25. PubMed ID: 26893553
[TBL] [Abstract][Full Text] [Related]
39. The distribution of COPD in UK general practice using the new GOLD classification.
Haughney J; Gruffydd-Jones K; Roberts J; Lee AJ; Hardwell A; McGarvey L
Eur Respir J; 2014 Apr; 43(4):993-1002. PubMed ID: 24176990
[TBL] [Abstract][Full Text] [Related]
40. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
